Against the backdrop of a Cas9 patent battle that refuses to die, Editas Medicine is cashing in a chunk of the licensing rights from Vertex Pharmaceuticals to the tune of $57 million. Last last ...

This is the first ICO to offer investors the chance to purchase the DOGIZ token directly from within Telegram itself and could open up a whole new slice of the crypto community. DOGIZ will go on ...

Sept 26 (Reuters) - Pfizer's (PFE.N), opens new tab decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental ...

A VAMPIRE tomb has been unearthed with a sickle around its neck to prevent the "monster" from ever rising. The tomb was discovered by archaeologists deep beneath a church in northern Poland after ...

The approval is based on the positive interim results from two global and ongoing clinical trials, CLIMB-121 in sickle cell disease and CLIMB-111 in transfusion-dependent beta thalassemia.

On Wednesday, Pfizer Inc. (NYSE:PFE) said the company is voluntarily withdrawing all lots of Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where ...

(Bloomberg) -- European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease complications in patients who started taking it.

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and doctors, leaving many searching for answers and scrambling for ways to ...

Have a great day, everyone. … Pfizer is removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths ...

(Reuters) - Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.

The company is discontinuing all active trials of the sickle cell disease treatment, voxelotor, globally. Credit: Sebastian Kaulitzki/Shutterstock. Pfizer has announced the voluntary withdrawal of all ...